1-3 of 3
Yogen Saunthararajah
Close
Sort by
Journal Articles

Key clinical observations after 5-azacytidine and decitabine treatment of myelodysplastic syndromes suggest practical solutions for better outcomes

Yogen Saunthararajah
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 511–521.
https://doi.org/10.1182/asheducation-2013.1.511
Published: 2013
Journal Articles

Hemoglobinopathies

George F. Atweh, Joseph DeSimone, Yogen Saunthararajah, Hassana Fathallah, Rona S. Weinberg, Ronald L. Nagel, Mary E. Fabry, Robert J. Adams
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 14–39.
https://doi.org/10.1182/asheducation-2003.1.14
Published: 2003
Journal Articles

Achievements in Understanding and Treatment of Myelodysplastic Syndromes

Eva Hellström-Lindberg, Cheryl Willman, A. John Barrett, Yogen Saunthararajah
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2000) 2000 (1): 110–132.
https://doi.org/10.1182/asheducation.V2000.1.110.110
Published: 2000